Event Date/Time: Sep 29, 2009
End Date/Time: Sep 30, 2009
The global generic pharmaceuticals market was worth over $100bn in 2007, with market growth noticeably higher that that of the overall pharmaceutical market. It is expected that over the period 2008 to 2013, the generic market will sustain its strong current growth, with exciting new developments to be driven by the wave of blockbuster drugs approaching patent expiry.Globally, drugs worth $70 billion would be going off-patent by 2011. While generic pharmaceuticals companies are heartened at the plentiful opportunities for the generics market upon branded medicines patent expiration, pharmaceutical companies are strategizing to retain their market share via setting up of generic subsidiaries, strategic partnerships with generic manufacturers, on top of mergers and acquisitions. With competition getting stiffer in the generics market, evolving business models and strategies to expedite market capture and overcome market barriers become critical. 4th Annual Generics Asia Summit aims to provide a platform for examining the growing global generic pharmaceuticals industry, dynamics of the Asian market, the revolutionising business as well as strategies from top players that enable them to spearhead the market.
For further information on speaking, exhibition and sponsorship opportunities, please contact Ms Sophia Lim at +65 6514 4187 or email at firstname.lastname@example.org